Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Level ll Quote
View:
Post by knoxt on Jan 10, 2022 12:51pm

Level ll Quote

 

THERALASE TECHNOLOGIES INC (CA: TLT)


          
Real-time  

Last: 0.325   Change: -0.010    Volume: 60,550   Last Trade: 12:28  

  Level ll Quote
  Bid   Ask
  Price   Total Size   # of Orders   Price   Total Size   # of Orders
$0.325 1000 1 $0.335 22500 4
$0.32 5000 1 $0.34 26500 2
$0.315 19500 4 $0.345 13000 3
$0.31 15000 2 $0.35 46000 5
$0.305 5000 1 $0.36 3500 2
$0.30 13500 1 $0.365 87500 1
$0.29 1000 1 $0.37 47500 2
$0.285 27500 1 $0.38 32000 8
$0.28 15500 2 $0.39 1500 1
$0.275 31000 1 $0.395 35000 2
Comment by langosta on Jan 10, 2022 4:12pm
Busy doing a lot of paper shredding this aft. Came across some old notes that I had written from 2014/2015/2016 on hopes and expectations of Theralase.   I don't believe how naive I was.  Especially so upbeat after listening to Kere Reports.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250